Profile: Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

124.61USD
4 May 2015
Change (% chg)

$2.00 (+1.63%)
Prev Close
$122.61
Open
$122.56
Day's High
$124.62
Day's Low
$122.56
Volume
46,258
Avg. Vol
58,667
52-wk High
$125.30
52-wk Low
$101.95

Search Stocks

Teleflex Incorporated, incorporated on June 25, 1943, is a medical technology company. The Company is a provider of medical technology products to enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. The Company designs, develops, manufactures and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The products platforms are categorized in four groups: Critical Care, Surgical Care, Cardiac Care and, OEM and Development Services. Critical Care, provides specialty products for critical care comprised of single-use products. Surgical Care, comprised of single-use products, including ligation and closure products; access ports used in invasive surgical procedures; and fluid management products used for chest drainage. Cardiac Care, includes diagnostic catheters and capital equipment. OEM and Development Services, develops and markets original equipment manufacturers.

Critical Care

The Company is a provider of specialty products for critical care, which is comprised of single-use products. The critical care products are used in procedures for vascular access, anesthesia and airway management, respiratory therapy, treatment of urologic conditions and other specialty procedures. The critical care products are sold to the hospitals and healthcare providers as well as home care, emergency medical services, long term care centers, primary care centers, hospice and animal health facilities.

Surgical Care

The Company provides surgical care products sales which are comprised of single-use products, including: ligation and closure products, such as appliers, clips and sutures used in surgical procedures; access ports used in minimally invasive surgical procedures as well as robotic surgery; and fluid management products used for chest drainage. The Company’s surgical products also include reusable hand-held instruments for general and specialty surgical procedures. They market surgical products under the Deknatel, Pilling, Pleur-evac, Taut and Weck brand names.

Cardiac Care

The Company’s Cardiac Care Products include diagnostic catheters and capital equipment. The Company diagnostic catheters include thermodilution and wedge pressure catheters; specialized angiographic catheters, such as Berman and Reverse Berman catheters; therapeutic delivery catheters, such as temporary pacing catheters; sheaths for femoral and trans-radial aortic access used in diagnostic and therapeutic procedures; and intra-aortic balloon. Capital equipment includes intra-aortic balloon pump, and consoles. The products are used to augment oxygen delivery to the cardiac muscle and reduce the oxygen demand after cardiac surgery, serious heart attack or interventional procedures. The Company market cardiac care products under the Arrow brand name.

OEM and Development Services

The Company product development and production services are marketed to original equipment manufacturers. The OEM division, includes the TFX OEM and Deknatel OEM nameplates, provides custom-engineered extrusions, diagnostic and interventional catheters, sheath and dilator sets introducers and kits, sutures, performance fibers, and bioresorbable resins and fibers. They offer an extensive portfolio of integrated capabilities, including engineering, material selection, regulatory affairs, prototyping, testing and validation, manufacturing, assembly, and packing.

Company Address

Teleflex Inc

550 E Swedesford Rd Ste 400
WAYNE   PA   19087-1601
P: +1610.2256800
F: +1610.9485101

Company Web Links

Search Stocks